1 completed, 1 recruiting. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Recruiting 1 |
| Phase 1 | 1 | Completed 1 |
Follow Interleukin-22: new trials by email Literature Review of Interleukin-22 trials Research Report on Interleukin-22
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Integrated Therapies for Alcohol Use in Alcohol-associated Liver Disease (ITAALD) Trial IL-22, Prednisone, Acamprosate - Alcohol-associated Hepatitis | Phase 2 | Recruiting | Samer Gawrieh | 216 | 2026-01-27 | 2026-07-15 |
| Study of IL-22 IgG2-Fc (F-652) for Subjects With Grade II-IV Lower GI aGVHD Recombinant Human Interleukin-22 IgG2-Fc (F-652), Systemic Corticosteroids - Acute Graft vs Host Disease | Phase 1 / Phase 2 | Completed | EVIVE Biotechnology | 30 | 2016-05-12 | 2021-07-22 |
EVIVE Biotechnology (1) · Samer Gawrieh (1)
United States (2)
U24AA026969 (1)